RTW Investments’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

RTW Investments’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,400	Closed	-$1.81M	–	81
2022 Q3	$1.81M	Sell	75,400 -5,850	-7%	-$151K	0.04%	82
2022 Q2	$1.61M	Hold	81,250	–	–	0.04%	98
2022 Q1	$2.92M	Hold	81,250	–	–	0.06%	86
2021 Q4	$3.64M	Hold	81,250	–	–	0.05%	101
2021 Q3	$5.79M	Hold	81,250	–	–	0.09%	89
2021 Q2	$10.7M	Hold	81,250	–	–	0.16%	71
2021 Q1	$10.9M	Buy	+81,250	New	+$10.3M	0.17%	68

Other funds holding ASLN

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Temasek Holdings

Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Waterfront Wealth Overland Park, Kansas $545M AUM 19.05% 1-Year Est. Return

Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return